Медицинская литература. Новинки

 

 

 

 

 

 

Контраст-индуцированная нефропатия

Вы можете загрузить полный текст статьи в формате pdf

Контраст индуцированная нефропатия (КИН), согласно рекомендациям Европейского общества уроради ологов (ЕОУР), определяется как ''острое нарушение по чечной функции вследствие введения йодированных контрастных средств (КС) при отсутствии других при чин''. Более правильно КИН следует определять как ''острое нарушение почечной функции, требующее времен ного или продолжительного применения диализа, всле дствие введения КС при отсутствии других причин''.

Ключевые слова:
контраст-индуцированная нефро патия, контрастные вещества

Литература:
1. Aspelin P, Aubry P, Fransson SG et al.: Nephrotoxic effects
in high risk patients undergoing angiography.
N.Engl.J.Med. 348:491 499, 2003.
2. Bagshaw SM, McAlister FA, Manns BJ et al.:
Acetylcysteine in the prevention of contrast induced
nephropathy: a case study of the pitfalls in the evolution of
evidence. Arch.Intern.Med. 166:161 166, 2006.
3. Barrett BJ, Katzberg RW, Thomsen HS et al.: Contrast
Induced Nephropathy in Patients With Chronic Kidney
Disease Undergoing Computed Tomography: A Double29. Stacul F, Adam A, Becker CR et al.: Strategies to reduce
the risk of contrast induced nephropathy. Am.J.Cardiol.
98:59K 77K, 2006.
30. Tepel M, Aspelin P, Lameire N: Contrast Induced
Nephropathy, A Clinical and Evidence Based Approach.
Circulation 113:1799 1806, 2006.
31. Thomsen HS, Morcos SK: Contrast medium induced
nephropathy: is there a new consensus? A review of pub
lished guidelines. Eur.Radiol. 16:1835 1840, 2006.
32. Valente S, Lazzeri C, Giglioli C et al.: Contrast induced
nephropathy in urgent coronary interventions.
J.Cardiovasc.Med. 7:737 741, 2006.
Blind Comparison of Iodixanol and Iopamidol. Invest
Radiol. 41:815 821, 2006.
4. Barrett BJ, Parfrey PS: Clinical practice. Preventing
nephropathy induced by contrast medium. N.Engl.J.Med.
354:379 386, 2006.
5. Carraro M, Malalan F, Antonione R et al.: Effects of a
dimeric vs a monomeric nonionic contrast medium on
renal function in patients with mild to moderate renal insuf
ficiency: a double blind, randomized clinical trial.
Eur.Radiol. 8:144 147, 1998.
6. Chalmers N, Jackson RW: Comparison of iodixanol and
iohexol in renal impairment. Br.J.Radiol. 72:701 703,
1999.
7. Erley C: Concomitant drugs with exposure to contrast
media. Kidney Int.Suppl.S20 S24, 2006.
8. Erley C, Thomsen HS, Morcos SK, Grazioli L, Bonomo L:
Contrast Induced Nephropathy (CIN) after Iomeprol 400
or Iodixanol 320 in Patients with Moderate to Severe
Chronic Kidney Disease: The ACTIVE Study. (abstract)
J.Am.Soc.Nephrol. 18: 2007.
9. Feldkamp T, Baumgart D, Elsner M et al.: Nephrotoxicity of
iso osmolar versus low osmolar contrast media is equal in
low risk patients. Clin.Nephrol. 66:322 330, 2006.
10. Franchini KG, Cowley AW, Jr.: Sensitivity of the renal
medullary circulation to plasma vasopressin. Am.J.Physiol
271:R647 R653, 1996
11. Freeman RV, O'donnell M, Share D et al.: Nephropathy
requiring dialysis after percutaneous coronary interven
tion and the critical role of an adjusted contrast dose.
Am.J.Cardiol. 90:1068 1073, 2002.
12. Gruberg L, Dangas G, Mehran R et al.: Clinical outcome
following percutaneous coronary interventions in patients
with chronic renal failure. Catheter.Cardiovasc.Interv.
55:66 72, 2002.
13. Jo SH, Youn TJ, Koo BK et al.: Renal toxicity evaluation
and comparison between visipaque (iodixanol) and hexa
brix (ioxaglate) in patients with renal insufficiency under
going coronary angiography: the RECOVER study: a ran
domized controlled trial. J.Am.Coll.Cardiol. 48:924 930,
2006.
14. Katayama H, Yamaguchi K, Kozuka T et al.: Adverse reac
tions to ionic and nonionic contrast media. A report from
the Japanese Committee on the Safety of Contrast Media.
Radiology. 175:621 628, 1990.
15. Liss P, Persson PB, Hansell P et al.: Renal failure in 57 925
patients undergoing coronary procedures using iso
osmolar or low osmolar contrast media. Kidney Int.
.70:1811 1817, 2006.
16. Mehran R: ICON Ionic Versus Non ionic Contrast To
Obviate Worsening Nephropathy After Angioplasty In
Chronic Renal Failure Patients. (abstract) Transcatheter
Cardiovascular Therapeutics 2006.
17. Mehran R, Nikolsky E: Contrast induced nephropathy: efi
nition, epidemiology, and patients at risk. Kidney
Int.Suppl.S11 S15, 2006.
18. Morcos SK, Thomsen HS, Webb JA: Contrast media
induced nephrotoxicity: a consensus report. Contrast
Media Safety Committee, European Society of Urogenital
Radiology (ESUR). Eur.Radiol. 9:1602 1613, 1999.
19. Moscucci M, Rogers EK, Montoye C et al.: Association of
a Continuous Quality Improvement Initiative With Practice
and Outcome Variations of Contemporary Percutaneous
Coronary Interventions. Circulation. : 2006.
20. Mueller C: Prevention of contrast induced nephropathy with
volume supplementation. Kidney Int.Suppl.S16 S19, 2006.
21. Newhouse JH, Kho D, Rao QA et al.: Frequency of serum
creatinine changes in the absence of iodinated contrast
material: implications for studies of contrast nephrotoxici
ty. AJR Am.J.Roentgenol. 191:376 382, 2008.
22. Persson P, Liss P, Hansell P: Evaluation and comparison
between visipaque (iodixanol) and hexabrix (ioxaglate) in cor
onary angiography. J.Am.Coll.Cardiol. 49: 1668 1669, 2007.
23. Rudnick MR, Davidson C, Laskey W et al.: Nephrotoxicity
of iodixanol versus ioversol in patients with chronic kidney
disease: the Visipaque Angiography/Interventions with
Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.
Am.Heart J. 156:776 782, 2008.
24. Seeliger E, Flemming B, Wronski T et al.: Viscosity of con
trast media perturbs renal hemodynamics.
J.Am.Soc.Nephrol. 18:2912 2920, 2007.
25. Sieber M, Jost G, Lengsfeld P, Seidensticker P: Influence
of the Viscosity and Osmolality of Iodinated Contrast
Agents on the Retention Time in the Kidney. (abstract)
J.Am.Soc.Nephrol. 18: 2007.
26. Solomon R, Barrett B: Follow up of patients with contrast
induced nephropathy. Kidney Int.Suppl.S46 S50, 2006
27. Solomon R, Deray G: How to prevent contrast induced
nephropathy and manage risk patients: practical recom
mendations. Kidney Int.Suppl.S51 S53, 2006.
28. Solomon RJ, Natarajan MK, Doucet S et al.: Cardiac
Angiography in Renally Impaired Patients (CARE) study: a
randomized double blind trial of contrast induced
nephropathy in patients with chronic kidney disease.
Circulation. 115:3189 3196, 2007.

Contrast Induced Nephropathy

Contrast induced nephropathy, according to recom mendations of European Society of Uroradiologists (ESU), is defined as an acute kidney's dysfunction resulting from injection of iodine contrast agents if any other reasons are absent. The more correct definition of contrast induced nephropathy is ''an acute kidney's dysfunction, requiring a short or long term hemodialysis''.

Keywords:
contrast-induced nephropathy, contrast agents